Centers | ||
UCSC Chemical Screening Center | DRSC at Harvard Medical School | Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR) |
We are a shared research facility dedicated to improving human health by finding therapeutic agents against a wide variety of diseases, dedicated to advancing scientific knowledge and technologies, and dedicated to education of the next generation of... |
Originally founded in 2003 to support RNAi screening in Drosophila cells, the DRSC has grown to include support for functional genomics screens in fly cells and in vivo, as well as for a number of bioinformatics analyses and visualization relevant to... |
Chulalongkorn
Drug Discovery and Drug Development Research Center (Chula4DR) was
established in 2017, with the aim to facilitate advancement of academic
drug discovery and drug development research by leveraging innovations
and sciences... Read more |
Partnerships |
Events |
Jobs |
California Institute for Quantitative Biosciences (QB3) QB3 isa tri-campus organization at UC Berkeley, UC San Francisco, and UC Santa Cruz. QB3 is the University of California’s hub for innovation and entrepreneurship in the life sciences. The institute supports UC researchers and empowers... View all GSK and MD Anderson to co-develop new cancer therapeuticsGlaxoSmithkline and MD Anderson Cancer Center entered into a co-development and license agreement to develop antibody based therapeutics to treat cancer. Under this agreement MD Anderson grants exclusive rights to antibodies developed during the... View all Creative BioMart
View all |
In this "Things You Need to Know" series on emerging technologies, we will learn from prominent... ![]() |
Assistant Director - ICCB-Longwood Screening Facility
... 06 April, 2022 Learn More Postdoc
id: 22536 T32 Postdoctoral Fellow position in microbiome and gut-brain axis research
id: 22537 Postdoctoral Associate -Laboratory of Immune Cell Epigenetics and Signaling
id: 22538 |